BIO Submits Comments on Electronic Distribution of Prescribing Information NPRM
<p>
The Biotechnology Industry Organization (BIO) thanks the Food and Drug Administration (FDA) for the opportunity to submit comments on the Proposed Rule entitled “Electronic Distribution of Prescribing Information for Human Prescription Drugs, Including Biological Products.”</p>
The Biotechnology Industry Organization (BIO) thanks the Food and Drug Administration (FDA) for the opportunity to submit comments on the Proposed Rule entitled “Electronic Distribution of Prescribing Information for Human Prescription Drugs, Including Biological Products.” BIO would like to thank the FDA for issuing this Proposed Rule requiring the electronic distribution of prescribing information (PI) for human drugs and biologics. We believe that once implemented, the rule will provide health care providers (HCPs) with the most recent FDA-approved PI, detailing a medicine’s safety, efficacy, and conditions of use, in a format that can be updated in a matter of days rather than weeks or months.
